Study of STI-3031 in Patients With Selected Relapsed or Refractory Solid Tumors

Stopped Intended to be replaced with another Protocol

Conditions

• Solid Tumor
• Refractory Tumor
• Relapsed Solid Tumor

Interventions

• BIOLOGICAL: STI-3031

Sponsor

Sorrento Therapeutics, Inc.